These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25668439)

  • 21. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.
    Hooper KA; Crowe JE; Bloom JD
    J Virol; 2015 Apr; 89(7):3737-45. PubMed ID: 25609803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts.
    Loyola PK; Campos-Rodríguez R; Bello M; Rojas-Hernández S; Zimic M; Quiliano M; Briz V; Muñoz-Fernández MA; Tolentino-López L; Correa-Basurto J
    Immunol Res; 2013 May; 56(1):44-60. PubMed ID: 23371837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of new monoclonal antibodies against swine origin 2009 influenza A (H1N1) virus and evaluation of their prophylactic and therapeutic efficacy in a mouse model.
    Wang SF; Tseng SP; Loh EW; Wang WH; Li MC; Chen KH; Tsai WC; Lee YM; Chen HY; Liu FT; Arthur Chen YM; Huang JC
    Dev Comp Immunol; 2017 Feb; 67():8-17. PubMed ID: 27984103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
    Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
    J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.
    Colman PM; Laver WG; Varghese JN; Baker AT; Tulloch PA; Air GM; Webster RG
    Nature; 1987 Mar 26-Apr 1; 326(6111):358-63. PubMed ID: 2436051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    Kirkpatrick Roubidoux E; Sano K; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
    J Virol; 2022 May; 96(9):e0033222. PubMed ID: 35446141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variability of the neuraminidase gene of influenza A(H1N1)pdm09 viruses circulating from the 2012/2013 to 2017/2018 season in Vojvodina Province, Serbia.
    Radovanov J; Ristic M; Medic S; Kovacevic G; Dopud N; Nikolic N; Patic A; Cvjetkovic IH; Petrovic V
    Mol Cell Probes; 2020 Aug; 52():101557. PubMed ID: 32147497
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
    Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
    Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5.
    Lee JT; Air GM
    Virology; 2006 Feb; 345(2):424-33. PubMed ID: 16297424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries.
    Tung CP; Chen IC; Yu CM; Peng HP; Jian JW; Ma SH; Lee YC; Jan JT; Yang AS
    Sci Rep; 2015 Oct; 5():15053. PubMed ID: 26456860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
    Wilson JR; Belser JA; DaSilva J; Guo Z; Sun X; Gansebom S; Bai Y; Stark TJ; Chang J; Carney P; Levine MZ; Barnes J; Stevens J; Maines TR; Tumpey TM; York IA
    Virology; 2017 Nov; 511():214-221. PubMed ID: 28888111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of A4 antibody for detection of neuraminidase I223R/H275Y-associated antiviral multidrug-resistant influenza virus.
    Guk K; Kim H; Lee M; Choi YA; Hwang SG; Han G; Kim HN; Kim H; Park H; Yong D; Kang T; Lim EK; Jung J
    Nat Commun; 2020 Jul; 11(1):3418. PubMed ID: 32647286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
    Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
    Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a linear epitope on the haemagglutinin protein of pandemic A/H1N1 2009 influenza virus using monoclonal antibodies.
    Chen Y; Zhang J; Qiao C; Wang J; Yang H; Chen H
    Arch Virol; 2014 Jun; 159(6):1413-9. PubMed ID: 24385157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear B-cell epitope mapping of neuraminidases of the 2009 A H1N1 viruses based on immunoinformatics.
    Huang P; Xu Y; Ni H; Zhong J; Zhang X; Tan S; Wu D; Qiu B; Guan D; Wen M; Yan J; Zhang Y
    Vaccine; 2011 Feb; 29(6):1278-82. PubMed ID: 21145374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.
    Zhu X; Turner HL; Lang S; McBride R; Bangaru S; Gilchuk IM; Yu W; Paulson JC; Crowe JE; Ward AB; Wilson IA
    Cell Host Microbe; 2019 Dec; 26(6):729-738.e4. PubMed ID: 31757767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.